Jou-Ku Chung

Jou-Ku Chung currently serves as the Global Head of Clinical Pharmacology at I-Mab Biopharma since June 2023. Prior roles include Head of Clinical Pharmacology and Translational Medicine at Astria Therapeutics, Inc. from September 2021 to June 2023 and Head of Clinical Pharmacology at Surface Oncology Inc. from February 2019 to September 2021. Jou-Ku Chung also held the position of Head of PKDM at Translate Bio from June 2017 to February 2019. At Shire, from June 2012 to June 2017, Jou-Ku Chung advanced through several key roles, including Director of Global DMPK and Associate Director of Clinical Pharmacology and Pharmacokinetics. Earlier career experience includes serving as Sr. Scientist in Clinical Pharmacology and Pharmacokinetics at Ironwood Pharmaceuticals and as a Scientist at Archemix between 2006 and 2010.